Innovita Research Foundation

I.R.F. / Survey / Chapter 6

Download printable version

Aging, The Molecular Concepts

Chapter 6 References

  1. Van Remmen H, Ward WF, Sabia RV, Richardson A. Gene expression and protein degradation. In: Masoro E, ed. Handbook of physiology: aging. Oxford: Oxford University Press, 1995: 171-234.
  2. Rattan SIS. Ageing - a biological perspective. Mol Aspects Med 1995: 16: 439-508.
  3. Laughrea M, Latulippe J. The poly(U) translation capacity of Fischer 344 rat liver does not deteriorate with age and is not affected by dietary regime. Mech Ageing Dev 1988: 45: 137^43.
  4. Holliday R. Understanding ageing. Cambridge: Cambridge University Press, 1995.
  5. Luce MC, Bunn CL. Decreased accuracy of protein synthesis in extracts from aging human diploid fibroblasts. Exp Gerontol 1989: 24: 113-25.
  6. Holliday R, Rattan SIS. Evidence that paromomycin induces premature ageing in human fibroblasts. Monogr Dev Biol 1984: 17: 221-33.
  7. Buchanan JH, Stevens A, Sidhu J. Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy. Eur J Cell Biol 1987:43: 141-7.
  8. Rattan SIS. Synthesis, modifications and turnover of proteins during aging. Exp Gerontol 1996: 31: 33-47.
  9. Kowald A, Kirkwood TBL. Accuracy of tRNA charging and codon: anticodon recognition; relative importance for cellular stability. J Theor Biol 1993: 160: 493-508.
  10. Pain VM. Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 1996: 236: 747-71.
  11. Chen ZP, Chen KY. Dramatic attenuation of hypusine formation on eukaryotic initiation factor 5A during senescence of IMR-90 human diploid fibroblasts. J Cell Physiol 1997: 170: 248-54.
  12. Borsatto B, Smith MAC. Reduction of the activity of ribosomal genes with age in Down's syndrome. Gerontology 1996: 42: 147-54.
  13. Shikama N, Brack C. Changes in the expression of genes involved in protein synthesis during Drosophila aging. Gerontology 1996: 42: 123-36.
  14. Nokazawa T, Mori N, Goto S. Functional deterioration of mouse liver ribosomes during aging: translational activity and the activity for formation of the 47S initiation complex. Mech Ageing Dev 1984:26:241-51.
  15. Spirin AS, Ryazanov AG. Regulation of elongation rate. In: Trachsel H, ed. Translation in eukaryotes. Boca Raton: CRC Press, 1991: 325-50.
  16. Khasigov PZ, Nikolaev AY. Age-related changes in the rates of polypeptide chain elongation. Biochemint 1987: 15: 1171-8.
  17. Merry BJ, Holehan AM. Effect of age and restricted feeding on polypeptide chain assembly kinetics in liver protein synthesis in vivo. Mech Ageing Dev 1991: 58: 139-50.
  18. Rattan SIS. Regulation of protein synthesis during ageing. Eur J Gerontol 1992: 1: 128-36.
  19. Nissen P, Kjeldgaard M, Thirup S, et al. Crystal structure of the ternary complex of Phe-tRNA1'116, EF-Tu, and a GTP analog. Science 1995: 270: 1464-72.
  20. Ann DK, Lin HH, Lee S, Tu ZJ, Wang E. Characterization of the statin-like Sl and rat elongation factor la as two distinctly expressed messages in rat. J Biol Chem 1992: 267: 699-702.
  21. ICnudsen SM, Frydenberg J, dark BFC, Letters H. Tissue-dependent variation in the expression of elongation factor-la isoforms: isolation and characterisation of a cDNA encoding a novel variant of human elongation factor la. Eur J Biochem 1993: 215: 549-54.
  22. Andersen LB, Lund A, Kveiborg M, dark BFC, Rattan SIS. From genes to functional gene products during ageing. In: Rattan SIS, Toussaint 0, eds. Molecular gerontology - research status and strategies. New York: Plenum Press, 1996: 53-73.
  23. Duttaroy A, Bourbeau D, Wang X-L, Wang E. Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-la. Exp Cell Res 1998: 238: 168-76.
  24. Cavallius J, Rattan SIS, dark BFC. Changes in activity and amount of active elongation factor-la in aging and immortal human fibroblast cultures. Exp Gerontol 1986: 21: 149-57.
  25. Rattan SIS, Cavallius J, Hartvigsen G, dark BFC. Amounts of active elongation factor-la and its activity in livers of mice during aging. Trends Aging Res 1986: 147: 135^0.
  26. Cavallius J, Rattan SIS, dark BFC. A decrease in levels ofmRNA for elongation factor-la accompanies the decline in its activity and the amounts of active enzyme in rat livers during aging. Topics Aging Res Eur 1989: 13: 125-32.
  27. Welle S, Thornton C, Bhatt K, ICrym M. Expression of elongation factor-la and Sl in young and old human skeletal muscle. J Gerontol Biol Sci 1997: 52A: B235-B9.
  28. Shepherd JCW, Walldorf U, Hug P, Gehring WJ. Fruitflies with additional expression of the elongation factor EF-la live longer. Proc Nati Acad Sci USA 1989: 86: 7520-1.
  29. Shikama N, Ackermann R, Brack C. Protein synthesis elongation factor EF-la expression and longevity in Drosophila melanogaster. Proc Nati Acad Sci USA 1994: 91: 4199-203.
  30. Steams SC, Kaiser M. The effects of enhanced expression of elongation factor EF-la on lifespan in Drosophila melanogaster. IV A summary of three experiments. Genetica 1993: 91: 167-82.
  31. Dudas SP, Arking R. The expression of the EFIa genes of Drosophila is not associated with the extended longevity phenotype in a selected long-lived strain. Exp Gerontol 1994: 29: 645-57.
  32. Riis B, Rattan SIS, dark BFC, Merrick WC. Eukaryotic protein elongation factors. Trends Biochem Sci 1990: 15: 420^.
  33. Riis B, Rattan SIS, Derventzi A, dark BFC. Reduced levels ofADP-ribosylatable elongation factor2 in aged and SV40-transformed human cells. FEBS Lett 1990: 266: 45-7.
  34. Rattan SIS, Ward WF, Glenting M, Svendsen L, Riis B, dark BFC. Dietary calorie restriction does not affect the levels of protein elongation factors in rat livers during aging. Mech Ageing Dev 1991: 58: 85-91.
  35. Bernier LW, E. A prospective view on phosphatases and replicative senescence. Exp Gerontol 1996: 31: 13-9.
  36. Campisi J, Dimri GP, Nehlin JO, Testori A, Yoshimoto K. Coming of age in culture. Exp Gerontol 1996: 31: 7-12.
  37. Atadja PW, Stringer KF, Riabowol KT. Loss of serum response element-binding activity and hyperphosphorylation of serum response factor during cellular aging. Mol Cell Biol 1994: 14: 4991-9.
  38. Merrick WC. Mechanism and regulation of eukaryotic protein synthesis. Microbiol Rev 1992: 56: 291-315.
  39. Celts JE, Madsen P, Ryazanov AG. Increased phosphorylation of elongation factor 2 during mitosis in transformed human amnion cells correlates with a decreased rate of protein synthesis. Proc Nati AcadSci USA 1990: 87: 4231-5.
  40. Riis B, Rattan SIS, Palmquist K, Nilsson A, Nygard 0, dark BFC. Elongation factor 2-specific calcium and calmodulin dependent protein kinase III activity in rat livers varies with age and calorie restriction. Biochem Biophys Res Commun 1993: 192: 1210-6.
  41. Riis B, Rattan SIS, Palmquist K, dark BFC, Nygard 0. Dephosphorylation of the phosphorylated elongation factor-2 in the livers of calorie-restricted and freely-fed rats during aging. Biochem Mol Biol Int 1995: 35: 855-9.
  42. Kihara F, Ninomyia-Tsuji J, Ishibashi S, Ide T. Failure in S6 protein phosphorylation by serum stimulation of senescent human diploid fibroblasts, TIG-1. Mech Ageing Dev 1986: 20: 305-13.
  43. Blumenthal EJ, Miller ACK, Stein GH, Malkinson AM. Serine/threonine protein kinases and calcium-dependent protease in senescent IMR-90 fibroblasts. Mech Ageing Dev 1993: 72: 13-24.
  44. Shall S. ADP-ribosylation reactions. Biochimie 1995: 77: 313-8.
  45. Dell'Orco RT, Anderson LE. Decline of poly(ADP-ribosyl)ation during in vitro senescence in human diploid fibroblasts. J Cell Physiol 1991: 146: 216-21.
  46. Burkle A, Grube K, Kiipper J-H. Poly(ADP-ribosyl)ation: its role in inducible DNA amplification, and its correlation with the longevity of mammalian species. Exp Clin Immunogenet 1992: 9: 230-40.
  47. Dell'Orco RT, McClung JK, Jupe ER, Liu X-T. Prohibitin and the senescent phenotype. Exp Gerontol {996: 31: 245-52.
  48. Rattan SIS, Derventzi A, dark BFC. Protein synthesis, post-translational modifications and aging. Ann NYAcad Sci 1992: 663: 48-62.
  49. Stadtman ER. Protein oxidation and aging. Science 1992: 257: 1220^.
  50. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS. Age-related loss of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Nati Acad Sci USA 1996: 93: 4765-9.
  51. Lee AT, Cerami A. Role of glycation in aging. Ann NY Acad Sci 1992: 663: 63-70.
  52. Oimomi M, Maeda Y, Hata F, et al. A study of the age-related acceleration of glycation of tissue proteins in rats. J Gerontol 1988: 43: B98-101.
  53. Miksik I, Deyl Z. Changes in the amount of e-hexosyllysine, UV absorbance, and fluorescence of collagen with age in different animal species. J Gerontol 1991: 46: Blll-6.
  54. Sell DR, Lane MA, Johnson WA, et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Nati Acad Sci USA 1996: 93: 485-90.
  55. Makita Z, Vlassara H, Rayfield E, et al. Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 1992: 258: 651-3.
  56. Gafni A. Age-related effects in enzyme metabolism and catalysis. Rev Biol Res Aging 1990: 4: 315-36.
  57. Brunauer LS, Clarke S. Age-dependent accumulation of protein residues which can be hydrolyzed to D-aspartic acid in human erythrocytes. J Biol Chem 1986: 261: 12538^3.
  58. Luthra M, Ranganathan D, Ranganathan S, Balasubramanian D. Racemization of tyrosine in the insoluble protein fraction of brunescent aging human lenses. J Biol Chem 1994: 269: 22678-82.
  59. Rosenberry TL, Krall JA, Dever TE, Haas R, Louvard D, Merrick WC. Biosynthetic incorporation of (3H)ethanolamine into protein synthesis elongation factor 1 alpha reveals a new post-translational protein modification. J Biol Chem 1989: 264: 7096-9.
  60. Park MH, Wolff EC, Folk JE. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. BioFactors 1993: 4: 95-104.
  61. Huttner WB. Protein tyrosine sulfation. Trends Biochem Sci 1987: 12: 361-3.
  62. Marshall CJ. Protein prenylation: a mediator of protein-protein interactions. Science 1993: 259: 1865-6.
  63. Thelin A, Runquist M, Ericsson J, Swiezewska E, Dallner G. Age-dependent changes in rat liver prenyltransferases. Mech Ageing Dev 1994: 76: 165-76.
  64. Ogryzko VY, Hirai TH, Russanova VR, Barbie DA, Howard BH. Human fibroblast commitment to a senescent-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol Cell Biol 1996: 16: 5210-9.
  65. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication ofpentoses in the aging process. J Biol Chem 1989: 264: 21597-602.
  66. Birckbichler PJ, Anderson LE, DelPOrco RT. Transglutaminase, donor age, and in vitro cellular senescence. Adv Exp Med Biol 1988: 231: 109-17.
  67. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Nati Acad Sci USA 1991: 88: 10257-61.
  68. Saunders NA, Smith RJ, Jetten AM. Regulation of proliferation-specific and differentiation-specific genes during senescence of human epidermal keratinocyte and mammary epithelial cells. Biochem Biophys Res Commun 1993: 197: 46-54.
  69. Norsgaard H, dark BFC, Rattan SIS. Distinction between differentiation and senescence and the absence of increased apoptosis in human keratinocytes undergoing cellular aging in vitro. Exp Gerontol\996: 31: 563-70.
< Previous | Contents | Next >